THE TAKETrailAI · auto-generated
Mullin's fundraising profile is fairly balanced between PAC money and individual donors, with 43 percent of his $2.7 million raised coming from committees and 57 percent from individuals. Industry-tied contributions show concentration in pharmaceuticals and biotech (18 percent), labor unions (14 percent), and lawyers and lobbyists (13 percent), with health services and government sectors each representing 7 percent; his individual donor base reflects similar patterns, drawing notably from the legal, government, and pharmaceutical sectors. He has cast 145 recorded votes and filed no stock trade disclosures.
Raised · all cycles$2.7M▼ 35% in ’24 vs ’22#173 in party · by cycle ↴
Top sector share18%Pharmaceuticals & Biotech
Donor-sector votes6on bills touching top donor sectors
FOLLOW THE MONEY
Left: who funds Mullin (ribbon width = dollars) · right: their votes on bills classified as favoring vs limiting those sectors
“Favors / limits” is an AI classification of each bill's likely effect on the sector — a factual reading of the bill, not a claim about motive. Correlation, not causation. The named bills are in DOES THE MONEY MATCH THE VOTES? below.
DOES THE MONEY MATCH THE VOTES?
How Mullin voted on bills touching their biggest donor sectors
Each dollar figure is Mullin's total from that donor sector — shown on each related vote, not a per-vote amount. Correlation between funding and votes, not causation; many factors shape any single vote.
TOP SOURCES
1$174K
UNITED DEMOCRACY PROJECT ('UDP')
PAC
2$51K
STATE OF CALIFORNIA
employees
3$50K
GENENTECH
employees
4$33K
COTCHETT, PITRE & MCCARTHY, LLP
employees
5$30K
ARTICHOKE JOES
employees
ALIGNMENT SIGNALS
Committee–Donor Overlap71%
Kevin Mullin (D) sits on the Energy and Commerce committee overseeing Pharmaceuticals & Biotech — their largest tracked donor sector (16%)
Kevin Mullin (D-CA) serves on the House Committee on Energy and Commerce, which has jurisdiction over the Pharmaceuticals & Biotech sector. Pharmaceuticals & Biotech is his largest donor sector at 15.9% of contributions ($0.43M), ranking second among House Democrats.
Sector-Aligned Voting70%
Kevin Mullin (D) voted YEA on just 1 of 4 bills classified as favoring their own donor sectors
Kevin Mullin voted in favor of 1 of 4 bills classified by an AI model as favoring Securities & Investment and Technology sectors among his top donors, representing 25% alignment. He voted against HJRES25-119, a congressional disapproval rule classified as favoring Securities & Investment, and opposed the only tracked bill classified as limiting these sectors.
COMMITTEES
Energy and Commerce
SIMILAR DONOR NETWORKS
Members funded by the same industries — overlapping donor networks may reflect shared policy interests.
Bonnie Watson Coleman
D-NJ · House
Pharmaceuticals & BiotechLabor UnionsLawyers & Lobbyists
Diana DeGette
D-CO · House
Pharmaceuticals & BiotechLabor UnionsLawyers & Lobbyists
Nanette Diaz Barragán
D-CA · House
Pharmaceuticals & BiotechLabor UnionsLawyers & Lobbyists
Robin L. Kelly
D-IL · House
Pharmaceuticals & BiotechLabor UnionsLawyers & Lobbyists
Janice D. Schakowsky
D-IL · House
Labor UnionsLawyers & LobbyistsHealth Services
Frederica S. Wilson
D-FL · House
Labor UnionsLawyers & LobbyistsHealth Services